NEW YORK, Feb. 15, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers
of Agile Therapeutics, Inc. securities (NASDAQ:AGRX) from March 9, 2016 through January 3, 2017, inclusive (the “Class Period”) of
the important March 7, 2017 lead plaintiff deadline. The lawsuit seeks to recover damages for Agile Therapeutics investors under
the federal securities laws.
To join the Agile Therapeutics class action, go to http://rosenlegal.com/cases-1022.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at
866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL
UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR
CHOICE.
According to the lawsuit, throughout the Class Period defendants issued materially false and misleading statements
to investors and/or failed to disclose that: (1) the Twirla contraceptive patch had an efficacy rating that fell below peer group
standards; (2) over half of the patients in its “Secure” Phase 3 Study discontinued the study early; (3) the Twirla patch therefore
allegedly had a slight chance of FDA approval; and (4) as a result, defendants’ positive statements about Agile Therapeutics’
business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When the true details entered the
market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no
later than March 7, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the
litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1022.html or to discuss your rights or interests regarding this
class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at
pkim@rosenlegal.com or kchan@rosenlegal.com. Attorney Advertising. Prior results do not guarantee a similar
outcome.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions
and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com kchan@rosenlegal.com www.rosenlegal.com
